BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2
36 results:

  • 1. Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery.
    Kirkwood JM; Vecchio MD; Weber J; Hoeller C; Grob JJ; Mohr P; Loquai C; Dutriaux C; Chiarion-Sileni V; Mackiewicz J; Rutkowski P; Arenberger P; Quereux G; Meniawy TM; Ascierto PA; Menzies AM; Durani P; Lobo M; Campigotto F; Gastman B; Long GV
    Future Oncol; 2024 May; 20(15):959-968. PubMed ID: 38390818
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cytotoxic effects of Chartergellus communis wasp venom peptide against melanoma cells.
    Bastos V; Pascoal S; Lopes K; Mortari M; Oliveira H
    Biochimie; 2024 Jan; 216():99-107. PubMed ID: 37879427
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Phenotypic distinctions in depression and anxiety: a comparative analysis of comorbid and isolated cases.
    Gao YN; Coombes B; Ryu E; Pazdernik V; Jenkins G; Pendegraft R; Biernacka J; Olfson M
    Psychol Med; 2023 Dec; 53(16):7766-7774. PubMed ID: 37403468
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
    Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
    J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gene Profiling of
    Poommarapan K; Rummaneethorn P; Srisubat A; Suwanpidokkul N; Leenutaphong P; Nararatwanchai T; Srihirun S; Phetchengkao W; Suriyachan K; Tancharoen S
    Anticancer Res; 2023 Mar; 43(3):1221-1237. PubMed ID: 36854502
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phytochemical Constituents and Derivatives of
    Schanknecht E; Bachari A; Nassar N; Piva T; Mantri N
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614303
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes.
    Modaresi F; Talachian K
    Pharmaceut Med; 2022 Dec; 36(6):387-400. PubMed ID: 36357543
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inadequate Activation of γδT- and B-cells in Patient with Wiskott-Aldrich Syndrome (WAS) Portrayed by TRG and IGH Repertoire Analyses.
    Palevski D; Simon A; Lev A; Somech R; Lee YN
    J Clin Immunol; 2023 Jan; 43(1):109-122. PubMed ID: 36044170
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
    Truong TH; Alcantara KP; Bulatao BPI; Sorasitthiyanukarn FN; Muangnoi C; Nalinratana N; Vajragupta O; Rojsitthisak P; Rojsitthisak P
    Carbohydr Polym; 2022 Jul; 288():119401. PubMed ID: 35450653
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cannabinoids: Therapeutic Use in Clinical Practice.
    Pagano C; Navarra G; Coppola L; Avilia G; Bifulco M; Laezza C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328765
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Whole-transcriptome sequencing-based concomitant detection of viral and human genetic determinants of cutaneous lesions.
    Saeidian AH; Youssefian L; Huang CY; Palizban F; Naji M; Saffarian Z; Mahmoudi H; Goodarzi A; Sotoudeh S; Vahidnezhad F; Amani M; Tavakoli N; Ajami A; Mozafarpoor S; Teimoorian M; Dorgaleleh S; Shokri S; Shenagari M; Abedi N; Zeinali S; Fortina P; Béziat V; Jouanguy E; Casanova JL; Uitto J; Vahidnezhad H
    JCI Insight; 2022 Apr; 7(8):. PubMed ID: 35316210
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties.
    Audrito V; Moiso E; Ugolini F; Messana VG; Brandimarte L; Manfredonia I; Bianchi S; De Logu F; Nassini R; Szumera-Ciećkiewicz A; Taverna D; Massi D; Deaglio S
    J Transl Med; 2022 Mar; 20(1):118. PubMed ID: 35272691
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Interaction of Glia Cells with Glioblastoma and Melanoma Cells under the Influence of Phytocannabinoids.
    Hohmann U; Walsleben C; Ghadban C; Kirchhoff F; Dehghani F; Hohmann T
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011711
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Current Understanding of the Roles of CD1a-Restricted T Cells in the Immune System.
    Yoo HJ; Kim NY; Kim JH
    Mol Cells; 2021 May; 44(5):310-317. PubMed ID: 33980746
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tetrahydrocannabinol and skin cancer: Analysis of YouTube Videos.
    Mamo A; Szeto MD; Mirhossaini R; Fortugno A; Dellavalle RP
    JMIR Dermatol; 2021 May; 4(1):e26564. PubMed ID: 37632811
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases.
    Ludwig J; Haubold J; Heusner TA; Bauer S; Siveke JT; Richly H; Wetter A; Umutlu L; Theysohn JM
    Rofo; 2021 Jun; 193(6):683-691. PubMed ID: 33348383
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies.
    Bachari A; Piva TJ; Salami SA; Jamshidi N; Mantri N
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839414
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Honeybee and wasp venom allergy: Sensitization and immunotherapy.
    Adib-Tezer H; Bayerl C
    J Dtsch Dermatol Ges; 2018 Oct; 16(10):1228-1247. PubMed ID: 30300499
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Loss of N-wasp drives early progression in an Apc model of intestinal tumourigenesis.
    Morris HT; Fort L; Spence HJ; Patel R; Vincent DF; Park JH; Snapper SB; Carey FA; Sansom OJ; Machesky LM
    J Pathol; 2018 Jul; 245(3):337-348. PubMed ID: 29672847
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Modulation of Melanotransferrin and Transferrin Receptor 1 (TFRC)- and CD44-based Signaling for TFRC Up-regulation in Human Melanoma Cells.
    Laube F; Glanz D
    Anticancer Res; 2017 Jun; 37(6):3001-3007. PubMed ID: 28551638
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.